###begin article-title 0
###xml 44 53 <span type="species:ncbi:7955">zebrafish</span>
The role of survivin in angiogenesis during zebrafish embryonic development
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin-1 </italic>
###xml 240 249 240 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 408 411 408 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 461 464 461 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 479 490 479 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin-1 </italic>
###xml 608 621 608 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 673 677 673 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 684 687 684 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 1066 1070 1066 1070 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 1077 1080 1077 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 1267 1276 1267 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 1296 1305 1296 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 95 104 <span type="species:ncbi:7955">zebrafish</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
###xml 320 329 <span type="species:ncbi:7955">zebrafish</span>
###xml 469 478 <span type="species:ncbi:7955">zebrafish</span>
###xml 1324 1329 <span type="species:ncbi:9606">human</span>
###xml 1615 1624 <span type="species:ncbi:7955">zebrafish</span>
Survivin is the smallest member of the inhibitor of apoptosis (IAP) gene family. Recently, the zebrafish survivin-1 gene has been cloned, showing remarkable sequence identity and similarity over the BIR domain compared with human and mouse survivin gene. Here we investigated the role of survivin in angiogenesis during zebrafish development. Morpholinos (MOs) targeting the 5' untranslated region (UTR) (SurUTR) and sequences flanking the initiation codon (SurATG) of zebrafish survivin-1 gene were injected into embryos at 1-4 cell stage. Vasculature was examined by microangiography and GFP expression in Tg(fli1:EGFP)y1 embryos. Results: In embryos co-injected with SurUTR and SurATG-MOs, vasculogenesis was intact but angiogenesis was markedly perturbed, especially in the inter-segmental vessels (ISV) and dorsal longitudinal anastomotic vessels (DLAV) of the trunk, the inner optic circle and optic veins of developing eyes and the sub-intestinal vessels. Apoptosis was increased, as shown by TUNEL staining and increase in caspase-3 activity. Efficacy of SurUTR and SurATG-MOs was demonstrated by translation inhibition of co-injected 5'UTR survivin:GFP plasmids. The phenotypes could be recapitulated by splice-site MO targeting the exon2-intron junction of survivin gene and rescued by survivin mRNA. Injection of human vascular endothelial growth factor (VEGF) protein induced ectopic angiogenesis and increased survivin expression, whereas treatment with a VEGF receptor inhibitor markedly reduced angiogenesis and suppressed survivin expression. Conclusion: Survivin is involved in angiogenesis during zebrafish development and may be under VEGF regulation.
###end p 3
###begin title 4
Background
###end title 4
###begin p 5
###xml 194 195 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 388 389 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 390 391 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 477 478 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 514 523 510 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 708 709 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 411 417 <span type="species:ncbi:10090">murine</span>
###xml 526 531 <span type="species:ncbi:10090">mouse</span>
###xml 688 694 <span type="species:ncbi:10090">murine</span>
Survivin is the smallest member of the inhibitor of apoptosis (IAP) gene family containing a single Baculovirus IAP Repeat (BIR) domain and an extended -COOH terminal alpha-helical coiled coil [1]. Survivin is not expressed in most normal adult tissues but is highly expressed in solid and hematological malignancies, where it has been linked to increased angiogenesis and tumorigenesis [2,3]. During human and murine embryonic development, survivin is ubiquitously expressed [4]. However, homozygous knock-out of survivin in mouse ES cells results in disrupted microtubule formation and polyploidy as well as early embryonic fatality, precluding characterization of its functions during murine development [5]. As a result, the role of survivin during embryonic development remains unclear.
###end p 5
###begin p 6
###xml 24 35 24 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin-1 </italic>
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin</italic>
###xml 182 191 182 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 233 242 233 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">chordin </italic>
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 14 23 <span type="species:ncbi:7955">zebrafish</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 277 286 <span type="species:ncbi:7955">zebrafish</span>
###xml 498 507 <span type="species:ncbi:7955">zebrafish</span>
Recently, the zebrafish survivin-1 gene (abbreviated survivin) has been cloned, showing remarkable sequence identity and similarity over the BIR domain compared with human and mouse survivin gene [6]. Microarray analysis showed that survivin is significantly up-regulated in a zebrafish chordin morphant in which the intermediate cell mass (ICM, where vascular and primitive hematopoietic tissues arise) was expanded [7]. Here, we investigated if survivin plays a role in vascular formation during zebrafish embryonic development.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 26 35 <span type="species:ncbi:7955">zebrafish</span>
Expression of survivin in zebrafish embryos
###end title 8
###begin p 9
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 59 68 59 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 116 125 116 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Survivin </italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a&#8211;b</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 561 569 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 595 604 595 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 810 814 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk1</italic>
###xml 856 860 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c&#8211;d</xref>
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
Whole-mount in-situ hybridization was performed to examine survivin mRNA expression in zebrafish embryos at 26 hpf. Survivin was detected diffusely throughout the developing brain and neural tube. It was also expressed at the vicinity of the axial vasculature from which the inter-segmental vessels arise (Figure 1a-b). This was further confirmed in histological sectioning in which the areas corresponding to the developing axial vasculature and neural tube showed increased expression relative to the adjacent tissues (Figure 1b, insert). Furthermore, double in-situ hybridization showed that survivin was expressed in the developing axial vasculature dorsal to the intermediate cell mass (ICM), where gene encoding for embryonic hemoglobin alpha was expressed. The pattern was remarkably similar to that of flk1, a VEGF receptor tyrosine kinase (Figure 1c-d).
###end p 9
###begin p 10
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Survivin </italic>
###xml 391 400 391 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 493 501 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 564 573 564 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk1 </italic>
###xml 637 664 637 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">embryonic hemoglobin-&#945; </italic>
###xml 72 81 <span type="species:ncbi:7955">zebrafish</span>
Whole-mount in-situ hybridization showing the expression of survivin in zebrafish embryos. (a, b): Survivin is expressed diffusely in the developing central nervous system (white arrows) and the axial vasculature (arrowheads) at 26 hpf. Similar expression patterns were seen at 56 hpf (not shown). (b, insert): Coronal section of stained embryos at 26 hpf showing preferential expression of survivin at the vicinity of the dorsal aorta and the developing neural tube (circled). (c, d): Double in-situ hybridization showing remarkably similar expression pattern of survivin (c) and flk1 (d) (blue, dark arrowheads) in relation to that of embryonic hemoglobin-alpha (brown, white arrowheads). Pictures are representative of at least three separate experiments. NT: Neural Tube; M: Myotome; N: Notochord; Y: Yolk sac extension.
###end p 10
###begin title 11
Survivin morphants
###end title 11
###begin p 12
###xml 137 146 137 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 225 229 225 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 240 243 240 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 264 267 264 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 277 280 277 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a,c</xref>
###xml 523 527 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b,d</xref>
###xml 699 701 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
###xml 728 732 724 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 737 740 733 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 905 907 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2e</xref>
###xml 984 987 978 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 1034 1038 1028 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 1045 1048 1039 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 1099 1106 1093 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1106 1109 1100 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
The role of survivin during embryonic development was investigated by knocking-down its function using MOs. The phenotypic penetrance of survivin MOs was dose- and time-dependent. At 22 hpf, when injected with either 3 ng SurUTR or 3 ng SurATG-MOs (referred as SurUTRmo and SurATGmo embryos), most embryos had a relatively normal morphology (Figure 2a,c). However, at 48 hpf, 74.8 +/- 7.3% and 72.0 +/- 4.0% of embryos manifested "characteristic phenotypes" with reduced eye and head sizes and a mildly curved tail (Figure 2b,d). There was no overt tissue necrosis in these embryos. At 6 ng of either MOs, increasing numbers of embryos became severely deformed and died shortly after 48 hpf (Figure 2d, insert). Co-injecting SurATG + SurUTR-MOs (3 ng each) resulted in specific phenotypes in 79.4 +/- 7.2% embryos without increase in toxicity or mortality as compared with 3 ng of either MO alone (Figure 2e). The combination regimen remained significantly less toxic than that of SurUTR-MO at 6 ng. In all subsequent experiments, SurATG and SurUTR-MOs were co-injected at 3 ng each (referred as SurUTR+ATGmo embryos). Only embryos with characteristic phenotypes were investigated while those which were severely deformed were excluded from analysis.
###end p 12
###begin p 13
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 209 213 209 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 227 231 227 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 254 261 254 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG+UTR</sub>
###xml 394 402 394 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG+UTR </sub>
###xml 609 613 609 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 619 623 619 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 981 984 981 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 989 993 989 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 999 1007 999 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG+UTR </sub>
###xml 1105 1112 1105 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
Effects of survivin knock-down on embryonic development. (a, b): Wild-type (WT) embryos injected with random sequence morpholino at 22 hpf (a) and 48 hpf (b). (c, d): Embryos injected with a combination of SurATG (3 ng) and SurUTR morpholinos (3 ng) (SurATG+UTR) at 1-4 cell stage. Noted that while there was no significant morphological changes at 22 hpf, most of the embryos injected with SurATG+UTR morpholinos at 48 hpf showed a "characteristic phenotype" with reduced head and eye size (circled) and a mildly curved tail (arrowheads). Similar phenotypes were also seen in embryos injected with either SurATG or SurUTR morpholinos at various doses but not in WT embryos injected with random sequence. Insert (d) showed a severe phenotype at 48 hpf characterized by severely deformed embryos which did not survive beyond 48 hpf. These embryos were not included in the analysis. Each picture is representative of at least three experiments. (e): The dose-dependence of either SurATG, SurUTR or SurATG+UTR morpholinos. Optimal response was observed when embryos were co-injected with 3 ng of each MO (SurUTR+ATG). Results were expressed as mean +/- S.E.M. In each experiment, MOs at different doses were injected into the same batch of embryos and were scored at the same time. More than 40 embryos have been injected at each dosage.
###end p 13
###begin title 14
Effects of survivin knock-down on angiogenesis
###end title 14
###begin p 15
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 180 189 180 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 225 238 225 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a,c</xref>
###xml 468 475 468 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b,d</xref>
###xml 857 864 857 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 864 867 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 1172 1179 1172 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1179 1182 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 1198 1202 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e&#8211;h</xref>
###xml 1275 1279 1275 1279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 1285 1289 1285 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 74 83 <span type="species:ncbi:7955">zebrafish</span>
###xml 418 421 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 518 526 <span type="species:ncbi:405018">cardinal</span>
###xml 801 804 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
We have previously shown that survivin is significantly up-regulated in a zebrafish chordin morphant in which the ICM was expanded [7]. Therefore, we first examined the effects of survivin knock-down on vascular formation in Tg(fli1:EGFP)y1 embryos. In uninjected embryos, the axial circulation (AC), inter-segmental vessels (ISV), dorsal longitudinal anastomotic vessels (DLAV), vertebral and sub-intestinal vessels (SIV) were readily observable (Figure 3a,c). In SurUTR+ATGmo embryos, the dorsal aorta and posterior cardinal vein were patent, indicative of intact vasculogenesis (see additional file 1: Wild-type embryos and file 2: Survivin morphants). However, the development of vertebral and ISV was perturbed with defective or total absence of sprouting as well as failure to form the DLAV and SIV (Figure 3b,d). These defects were seen in all 54 SurUTR+ATGmo embryos observed (n = 3 separate experiments) with the characteristic phenotypes. The results were confirmed using microangiography in which defective ISV sprouting and failure to form the DLAV, as well as defective inner optic circle (IOC) and optic veins (OV) of the developing eyes were seen in the SurUTR+ATGmo embryos (Figure 3e-h). Similar patterns of angiogenesis defects were observed when either SurUTR or SurATG morpholinos were injected (data not shown).
###end p 15
###begin p 16
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 95 108 95 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 161 169 161 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG </sub>
###xml 381 388 381 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 595 608 595 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 608 611 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 685 692 685 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 692 695 692 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 766 773 766 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 773 776 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1009 1016 1009 1016 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1194 1201 1194 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1201 1204 1201 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 465 473 <span type="species:ncbi:405018">cardinal</span>
###xml 674 677 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Effects of survivin knock-down on angiogenesis and circulation. (a, b): Confocal microscopy of Tg(fli1:EGFP)y1 embryos either uninjected (a) or injected with SurUTR+ATG morpholinos (b). Noted the aberrant sprouting of the inter-segmental vessels (ISV) (arrowheads), the absence of vertebral arteries (arrows) and the failure to form the dorsal anastomotic vessels (DLAV) in the SurUTR+ATGMO embryos. AC: Axial circulation. Noted that the dorsal aorta and posterior cardinal vein in the axial circulation could not be distinguished based on the resolution provided. (c, d): Fluorescent images in Tg(fli1:EGFP)y1 embryos showing failure to develop the sub-intestinal vessels (SIV) in SurUTR+ATGMO embryos. (e-h): Microangiographic pictures in uninjected (e, g) and SurUTR+ATGMO embryos (f, h) showing defective vasculatures in ISV, DLAV, optical veins (OV) and inner optic circle (IOC). N: Notochord; AC: Axial circulation. (i, j): Whole-mount TUNEL assay in embryos injected with random sequence MO (i) and SurUTR+ATG-MO (j) showing positive staining in the area of developing neural tube and brain (white arrows) as well as at the vicinity of the axial circulation (white arrowheads) in the SurUTR+ATGMO embryos. N: Notochord; Y: Yolk sac extension. Embryos were examined at 48 hpf except (c) & (d) which were examined at 96 hpf. More than 20 embryos have been examined in each experiment.
###end p 16
###begin title 17
Effects of survivin MOs on apoptosis as shown by TUNEL and caspase-3 activity
###end title 17
###begin p 18
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 184 191 184 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3i,j</xref>
###xml 570 577 570 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 577 580 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
As a member of the IAP family, survivin has been shown to inhibit apoptosis by regulating caspase activity [1,2]. Therefore; we investigated if there was increased apoptosis in the SurUTR+ATGmo embryos as measured by TUNEL assay. At both 24 and 48 hpf, increased TUNEL staining was detected in the developing neural tube and the brain (not shown), with significant, albeit weaker, staining at the vicinity of the axial vasculature (Figure 3i,j). The increased apoptosis was further confirmed by specific caspase-3 activity which was significantly increased in 48 hpf SurUTR+ATGmo embryos (299.1 +/- 8.3 arbitrary units) compared with control embryos injected with a random sequence MO at 6 ng (103.0 +/- 2.3 arbitrary units, n = 3 experiments using 240 embryos, p < 0.05).
###end p 18
###begin title 19
Specificity of survivin knock-down
###end title 19
###begin p 20
###xml 42 46 42 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR </sub>
###xml 53 57 53 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG </sub>
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 160 167 160 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 269 273 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a,c</xref>
###xml 312 319 310 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 420 424 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b,d</xref>
###xml 448 450 446 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">SS</sub>
###xml 519 526 517 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 526 529 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 640 653 638 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 653 654 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 653 656 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 717 721 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e&#8211;f</xref>
###xml 971 973 969 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink">SS</sub>
###xml 973 976 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1140 1144 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4g,h</xref>
###xml 1316 1323 1314 1321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1323 1326 1321 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">mo </sup>
###xml 1351 1360 1349 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 1381 1388 1379 1386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1489 1493 1487 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4i&#8211;l</xref>
To further demonstrate the efficacy of SurUTR and SurATG MO binding to survivin mRNA, embryos were co-injected with a 5'UTR survivin:GFP plasmid (50 pg) and SurUTR+ATG-MOs (3 ng each). Injecting the plasmid alone lead to GFP expression in 79.7 +/- 9.4% embryos (Figure 4a,c). Co-injection of the plasmid with SurUTR+ATG-MOs completely abolished protein translation and hence GFP expression in all embryos tested (Figure 4b,d). A splice site MO (SurSS-MO (12 ng)) not only induced similar morphological changes as in SurUTR+ATGmo embryos (smaller head and eye size and mildly curved tail) but also induced defective angiogenesis as shown in Tg(fli1:EGFP)y1 embryos (61.7%, n = 3 experiments using 159 embryos) (Figure 4e-f). Angiogenesis defects were seen in ISV as well as OV/IOC of the developing eyes (not shown). A relatively high dose of MO (12 ng) was used as lower doses produced less phenotypic penetrance and at 12 ng, there was no excessive mortality. In the SurSSMO embryos, RT-PCR confirmed defective splicing of part of the intron, as shown by a larger PCR transcript which was verified by bi-directional DNA sequencing (Figure 4g,h). Whether defective splicing could be induced by lower doses of this MO has not been examined. Finally, defective sprouting or failure to form the DLAV occurred in all SurUTR+ATGmo embryos and co-injecting survivin mRNA (30 pg) with SurUTR+ATG-MOs rescued the vascular defect in 47 out of 58 embryos in three separate experiments (81%) (Figure 4i-l).
###end p 20
###begin p 21
###xml 10 19 10 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 225 232 223 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 233 236 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 260 273 258 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 273 274 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 273 276 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 376 383 374 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 383 386 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 444 453 442 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 564 573 562 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 695 702 693 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 702 705 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 751 760 749 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 799 806 797 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 806 809 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 826 833 824 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 833 836 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 861 870 859 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
Effect of survivin knock-down was gene-specific. (a-d): Injection of 5'UTR-survivin:GFP plasmids gave rise to green fluorescence in a mosaic pattern in 79.7 +/- 9.4% (a, c) which was totally abolished by co-injection with SurUTR+ATG-MO (b, d). (e): Uninjected Tg(fli1:EGFP)y1 embryos at 48 hpf. (f): Defective sprouting of inter-segmental vessels, similar to those seen in SurUTR+ATGMO embryos, could be recapitulated by injecting embryos with survivin morpholino targeting the splice-site junction (g). (h): Molecular targeting was confirmed using RT-PCR showing survivin gene in injected embryos contained a larger transcript compared with uninjected ones. (i-k): Defective angiogenesis in SurUTR+ATGMO embryos could be rescued by co-injecting with survivin mRNA. (i): Uninjected embryos. (j): SurUTR+ATGMO embryos. (k): SurUTR+ATGMO embryos co-injected with survivin mRNA. (i): Histogram showing average number of embryos with normal inter-segmental vessels (ISV) in three separate experiments. All embryos were oriented anterior (left) to posterior (right).
###end p 21
###begin title 22
Effects of VEGF on survivin expression
###end title 22
###begin p 23
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In-vitro </italic>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 249 258 249 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 729 738 729 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 762 768 762 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a&#8211;b,f</xref>
###xml 950 954 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c&#8211;d</xref>
###xml 984 993 983 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 1024 1026 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e</xref>
###xml 1029 1038 1028 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Survivin </italic>
###xml 1112 1114 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5f</xref>
###xml 52 61 <span type="species:ncbi:7955">zebrafish</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 366 375 <span type="species:ncbi:7955">zebrafish</span>
VEGF plays an important role in angiogenesis during zebrafish embryonic development [8]. In-vitro studies have shown that survivin mediates the proliferative and anti-apoptotic effects of VEGF in endothelial cells [9]. Therefore; we investigated if survivin expression during embryogenesis is regulated by VEGF. Exogenous human VEGF protein (2 ng) was injected into zebrafish embryos at one-cell stage [10]. Angiogenesis was examined in the sub-intestinal vessels at 96 hpf, where the vasculature was well-developed and any ectopic structures could be readily detectable. In 78 out of 110 embryos (70%) (from three separate experiments), VEGF induces ectopic angiogenesis which was associated with a significant up-regulation of survivin mRNA expression (Figure 5a-b,f). We also incubated embryos with a VEGF receptor inhibitor (VEGFTKR) at one-cell stage. VEGFTKR (25 mumol/L) induced defective angiogenesis in all treated embryos at 48 hpf (Figure 5c-d) and could not be rescued by survivin mRNA injection (30 pg) (Figure 5e). Survivin mRNA expression was significantly down-regulated in these embryos (Figure 5f).
###end p 23
###begin p 24
###xml 132 145 132 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 345 358 345 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 358 359 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 375 388 375 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 549 558 548 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 660 669 659 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 1018 1021 1015 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
Regulation of survivin expression by vascular endothelial growth factor (VEGF) at 96 hpf. (a): Sub-intestinal vessels in uninjected Tg(fli1:EGFP)y1 embryos. (b): Injection of human VEGF (2 ng) gave rise to ectopic angiogenesis (arrows). There was no observable ectopic angiogenesis in the ISV (c): Axial and inter-segmental vessels in untreated Tg(fli1:EGFP)y1 embryos. (d): Tg(fli1:EGFP)y1 embryos treated with VEGF tyrosine kinase receptor inhibitor (VEGFTKRI, 25 mumol/L) showing defective sprouting of inter-segmental vessels. (e): Injection of survivin mRNA did not reverse the defects seen in VEGFTKRI treated embryos. (f): Histogram showing the average survivin mRNA expression (expressed in fold-change) in untreated and VEGFTKRI treated embryos as well as in embryos injected with human VEGF. Results expressed in mean +/- S.E.M. (n = 3 experiments using at least 20 embryos per experiments). When the three groups of data were compared using Kruskal-Wallis Test, p-value = 0.016. When the data of uninjected vs VEGFTKRI treated embryos were compared using Mann-Whitney U Test, p-value = 0.037.
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 283 292 283 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 605 614 605 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vitro </italic>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
In this study, we demonstrated that knock-down of survivin with MOs gives rise to embryos with reduced eye and head sizes and a mildly curved tail. Similar phenotypic changes have been described in a survivin mutant generated in a retrovirus insertional mutagenesis screen [11]. The survivin morphants had defective angiogenesis but vasculogenesis, i.e. formation of axial vasculature, was not affected at the doses of MOs tested. Development delay in these morphants was not observed, as shown by the normal onset and pattern of pigmentation and heart beat (data not shown). Our results corroborate with in-vitro studies showing that survivin is important for the maintenance of proliferation and survival on endothelial cells [9,12]. In addition, our data provided new information on the role of survivin during embryonic development.
###end p 26
###begin p 27
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In-vitro </italic>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 285 296 285 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">schwentine </italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 382 386 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y10 </italic>
###xml 387 389 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 568 569 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 638 647 634 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 898 900 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1007 1014 1003 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1014 1017 1010 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1178 1180 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1249 1256 1245 1252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1256 1259 1252 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 114 123 <span type="species:ncbi:7955">zebrafish</span>
###xml 217 226 <span type="species:ncbi:7955">zebrafish</span>
###xml 774 783 <span type="species:ncbi:7955">zebrafish</span>
###xml 868 873 <span type="species:ncbi:9606">human</span>
In-vitro and tumorigenesis studies have shown that survivin mediates the angiogenic effects of VEGF [9,12,13]. In zebrafish embryos, VEGF signaling is important for angiogenesis. In particular, mutants defective in a zebrafish orthologue of flk1 (a VEGF-receptor tyrosine kinase), the schwentine [14], and in phospholipase Cgamma (a tyrosine kinase mediating effects of VEGFR), the y10 [15], exhibit specific defects in angiogenesis. MO targeting of VEGF results in defective circulation in the head, axial and inter-segmental vasculature in a dose-dependent fashion [8]. In this study, VEGF induces ectopic angiogenesis and up-regulates survivin mRNA expression, suggesting that survivin may mediate the angiogenic effect of VEGF. The link between VEGF and survivin during zebrafish angiogenesis has not been examined but may involve PKB/Akt signaling as reported in human endothelial cell lines [16]. Intriguingly, co-injecting embryos with survivin mRNA could only rescue the vascular defects seen in SurUTR+ATGMO embryos but not in embryos treated with a VEGF receptor inhibitor. Therefore, additional downstream mediators may be involved in the angiogenic effects of VEGF [17]. Reversely, whether VEGF can rescue the angiogenesis defects in SurUTR+ATGMO embryos has not been examined. Perturbation of VEGF signaling may also result in changes in blood vessel synthesis and the observed changes in survivin mRNA may reflect changes in endothelial cell number rather than a direct mechanistic link to VEGF signaling. This issue would have to be evaluated in future study.
###end p 27
###begin p 28
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 230 237 230 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 428 430 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 444 458 444 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(gata1:GFP) </italic>
###xml 5 10 <span type="species:ncbi:9606">human</span>
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Both human and murine studies have demonstrated that survivin is involved in haematopoietic stem and progenitor cell proliferation [18,19]. However, in the present study, early specification of hematopoietic progenitors in the SurUTR+ATGMO embryos was not affected, as shown by the normal expression of genes encoding for hematopoietic transcription factors and embryonic hemoglobins, as well as the normal distribution of gata1+ population in Tg(gata1:GFP) embryos at 18 hpf, before the onset of functional circulation (data not shown).
###end p 28
###begin p 29
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 134 141 134 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 186 195 186 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 380 387 380 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 548 555 548 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 640 647 640 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 671 680 671 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 937 944 937 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 991 998 991 998 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 998 1001 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1061 1070 1061 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 709 712 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 1082 1091 <span type="species:ncbi:7955">zebrafish</span>
That the targeting of the survivin MOs was specific was shown using several control studies. First, the phenotypic changes seen in SurUTR+ATGMO embryos were similar to those observed in survivin mutants generated by retrovirus insertional mutagenesis screening [11]. Indeed, it would be valuable to examine this mutant for similar defects in angiogenesis. Second, co-injecting SurUTR+ATG-MO with a 5'UTR-survivin:GFP plasmid inhibited translation and hence green fluorescence induced by the latter in all embryos, proving efficacious binding of SurUTR+ATG-MO to the 5'UTR-survivin mRNA. Third, the angiogenesis defects of ISV induced by SurUTR+ATG-MO could be rescued by survivin mRNA. Whether the defects in SIV and OV/IOC were similarly reversed and whether injection of survivin mRNA alone would induce angiogenesis defects would have to be further examined. Finally a splice-site morpholino recapitulated the phenotypes seen with SurUTR+ATG-MO. Therefore, the angiogenesis defects in SurUTR+ATGMO embryos represent a specific phenotype due to knock-down of survivin function in zebrafish embryos.
###end p 29
###begin p 30
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 176 183 176 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 442 451 442 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 633 641 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 679 688 679 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 739 743 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk1</italic>
###xml 835 844 835 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 992 999 992 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 999 1002 999 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1254 1261 1254 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 1261 1264 1261 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 1583 1585 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1682 1689 1682 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vivo</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 32 39 <span type="species:ncbi:8355">Xenopus</span>
###xml 423 432 <span type="species:ncbi:7955">zebrafish</span>
###xml 1627 1634 <span type="species:ncbi:8355">Xenopus</span>
In human, murine [4] as well as Xenopus embryos [20], survivin is ubiquitously expressed. These observations, together with the fact that the developing head and eye of the SurUTR+ATGMO embryos were reduced in size have raised a concern whether the angiogenesis defects in these embryos might be caused by a general developmental defect and cell death, rather than a specific requirement for survivin function. However, in zebrafish embryos, survivin is more robustly expressed in the axial vasculature as well as the developing brain and neural tube. This observation has been confirmed by histological sectioning as well as double in-situ hybridization in which the pattern of survivin expression showed remarkable similarity to that of flk1, a marker of vascular endothelium. We cannot exclude a low level but diffuse expression of survivin in adjacent tissues but this should not negate the specific role of survivin during angiogenesis. First, we have confined our examination to the SurUTR+ATGMO embryos with characteristic phenotypes and none of them showed overt tissue necrosis at 48 hpf. The 20% embryos with severe deformity have been excluded from analysis. Second, we demonstrated that embryonic development is not overtly delayed in the SurUTR+ATGMO embryos as shown by the normal onset and pattern of pigmentation and heart beat (data not shown). Finally, in the present study, survivin expression appeared to be under VEGF regulation, providing a possible link between VEGF and embryonic angiogenesis. Our findings were also consistent with those by Pasquier et al. [20] in which over-expression of survivin in Xenopus embryos induces endothelial cell proliferation in-vivo.
###end p 30
###begin p 31
###xml 182 189 182 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 320 327 320 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR+ATG</sub>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">MO </sup>
###xml 344 352 344 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vivo </italic>
###xml 356 365 356 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vitro </italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 589 598 589 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1556 1565 1556 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 2103 2105 2103 2105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 556 563 <span type="species:ncbi:8355">Xenopus</span>
###xml 943 952 <span type="species:ncbi:7955">zebrafish</span>
###xml 2049 2058 <span type="species:ncbi:7955">zebrafish</span>
###xml 2329 2338 <span type="species:ncbi:7955">zebrafish</span>
Several observations in this study have remained unexplained. For instance, we did not observe a direct causal link between increased apoptosis and the angiogenesis defect in the SurUTR+ATGMO embryos. Apoptosis was detectable not only in the axial vasculature, but also in the developing brain and neural tube of the SurUTR+ATGMO embryos. Both in-vivo and in-vitro studies have demonstrated that in addition to its anti-apoptotic function, survivin plays an important role in the regulation of cellular proliferation and cytokinesis [1,2]. Recent study in Xenopus embryos also showed that survivin expression induces endothelial cell proliferation independent of apoptosis [20]. Therefore, the relative modest TUNEL staining in the axial vasculature did not preclude the role of survivin in angiogenesis. It is also possible that survivin plays a non-cell autonomous role in the angiogenesis process. Childs et al. (2002) [21] demonstrated in zebrafish embryos the migration of angioblasts from the aorta to the dorsal aspect of the neural tube and to the inter-phase between notochord and the somites, where they develop into DLAV and ISV. Therefore, vascular patterning may depend on signaling cues that direct the site of angiogenesis sprouts. Whether the occurrence of apoptosis in the developing neural tube might have perturbed these signals hence the formation of DLAV and ISV would have to be carefully examined. The proposition may also explain the lack of robust expression at the site of ISV and DLAV in wild-type embryos. Furthermore, although survivin is expressed robustly in the axial vasculature, concomitant expression was noted in the developing central nervous system. The expression of survivin within these structures needs to be defined in future study. Moreover, the developing eye and head structures in the survivin morphants are generally smaller. Whether this reflected changes secondary to defective angiogenesis or alternative functions of survivin during development have not been elucidated. Finally, survivin gene in zebrafish has undergone duplication during evolution [22] and the function of the duplicated gene would have to be further investigated. Notwithstanding these limitations, our data still supported the proposition that survivin is involved in the regulation of angiogenesis during zebrafish development.
###end p 31
###begin p 32
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Survivin </italic>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 209 218 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 427 436 <span type="species:ncbi:7955">zebrafish</span>
###xml 479 488 <span type="species:ncbi:7955">zebrafish</span>
Survivin is strongly expressed in both solid organ and hematological malignancies where it is associated with treatment failure and a poor prognosis [2,3]. Loss of function studies have also demonstrated that survivin expression is linked to angiogenesis and tumorigenesis in gastric and colonic cancers and has become a potential target for anti-cancer therapy [23,24]. Our observation that survivin regulates angiogenesis in zebrafish embryos highlights the relevance of using zebrafish embryos in the screening for survivin-based anti-cancer agents.
###end p 32
###begin p 33
In summary, we demonstrate that survivin plays an important role in angiogenesis during embryonic development and may be one of the down-stream effectors of VEGF signaling. Early hematopoiesis was not affected but the role of survivin during late hematopoiesis remains to be determined.
###end p 33
###begin title 34
Methods
###end title 34
###begin title 35
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish and morpholinos
###end title 35
###begin p 36
###xml 21 32 21 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio</italic>
###xml 151 164 145 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(fli1:EGFP)</italic>
###xml 164 165 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 164 167 158 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 410 419 404 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 503 512 497 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 521 523 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">SS</sub>
###xml 603 604 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 760 761 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 762 764 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 765 767 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 10 19 <span type="species:ncbi:7955">zebrafish</span>
###xml 21 32 <span type="species:ncbi:7955">Danio rerio</span>
###xml 400 409 <span type="species:ncbi:7955">zebrafish</span>
Wild-type zebrafish (Danio rerio) were obtained from local aquarium and were maintained and raised under standard conditions at 28degreesC. Transgenic Tg(fli1:EGFP)y1 embryos were used to track endothelial cell populations. Anti-sense morpholinos (MO) (Gene-Tools, OR, USA) were designed to target the 5'untranslated region (UTR) or sequences flanking and including the initiation codon (ATG) of the zebrafish survivin gene. A splice-site (SS) MO was designed to target the exon2-intron junction of the survivin gene (SurSS-MO). A random sequence MO was used as a control as described previously (Table 1). Procedures for micro-injection, whole mount in-situ hybridization, microangiography, TUNEL and caspase-3 activity assays have been described previously [7,25,26].
###end p 36
###begin p 37
Sequences of oligos used.
###end p 37
###begin title 38
Double in-situ hybridization
###end title 38
###begin p 39
###xml 360 366 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk-1 </italic>
###xml 369 379 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin-1</italic>
Wild-type (WT) embryos at 24 hpf were fixed with 4% paraformaldehyde (PFA) and dehydrated. After stepwise re-hydration, the embryos were incubated in pre-hybridization buffer (50% formamide, 5 x SSC, 50 mug/ml heparin, 0.1% Tween20, 5 mg/ml rRNA in phosphate-buffered saline, PBS) at 65degreesC followed by overnight incubation with digoxigenin (DIG)- (either flk-1 or survivin-1) and fluorescein-labeled riboprobe (alpha-embryonic globin) at 65degreesC. The embryos were washed and incubated with alkaline phosphatase (AP) conjugated anti-DIG antibody (Roche Molecular Biochemicals, Mannheim, Germany) for overnight at 4degreesC. Blue color was developed using NBT/BCIP (Roche Molecular Biochemicals, Mannheim, Germany) as substrate and the reaction was stopped with 0.5 mM EDTA in PBT. AP was destroyed by washing the stained embryos with 0.1 M glycine-HCl, pH 2.2 in PBT for 10 min twice. Background staining was removed by washing the embryos in absolute ethanol with continuous monitoring. After re-hydration to PBT, embryos were incubated with AP conjugated anti-fluorescein antibody (Roche Molecular Biochemicals, Mannheim, Germany) for overnight at 4degreesC and red color was developed using INT/BCIP (Roche Molecular Biochemicals, Mannheim, Germany) as substrate.
###end p 39
###begin title 40
Synthesis of anti-sense mRNA riboprobe for survivin
###end title 40
###begin p 41
###xml 38 47 38 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 232 241 232 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
The full length sequence of zebrafish survivin including the 3' UTR was amplified by PCR (Table 1) from cDNA of 24 hpf embryos and subcloned into pGem-T vector (pGEM-T Vector Systems, Promega, Madison, WI, USA). A 623 bp anti-sense survivin mRNA riboprobe was synthesized from linearized vector containing the insert. A digoxigenin labeled mRNA probe was synthesized by SP6 RNA polymerase according the manufacturer's protocols (Roche Applied Science, Indianapolis, IN, USA). The size and integrity of the synthesized riboprobe was confirmed by RNA formaldehyde gel electrophoresis. Histological assessment of stained embryos was performed on 5-7-mum paraffin sections.
###end p 41
###begin title 42
Construction of 5'UTR-survivin:GFP plasmids
###end title 42
###begin p 43
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin</italic>
###xml 60 63 60 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">UTR</sub>
###xml 74 77 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATG</sub>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 352 360 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 352 359 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The 5'UTR of survivin, including the target sequences of SurUTR-MO and SurATG-MO, were amplified from 24 hpf wild-type embryo cDNA (Table 1). PCR products were gel purified and cloned in frame and immediately upstream of the GFP coding sequence into vector pcDNA3.1/CT-GFP-TOPO (Invitrogen, Carlsbad, CA, USA) and transformed into chemically competent E. coli TOP10 (Invitrogen, Carlsbad, CA, USA). Plasmids containing the 5'UTR-survivin:GFP fusion sequence were isolated and the sequence of the DNA inserts verified using the GFP reverse primer (5'-GGG TAA GCT TTC CGT ATG TAG C-3').
###end p 43
###begin title 44
Preparation of survivin mRNA for rescue experiments
###end title 44
###begin p 45
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal </italic>
The complete coding sequence of survivin was TA-cloned into pGEM-T vector (pGEM-T Vector Systems, Promega, Madison, WI, USA) and the orientation of the insert confirmed by PCR (Table 1). mRNA transcripts were synthesized from the T7 promoter of the Sal I digested pGEMT-Sur sequence using the mMessage mMachine Kit (Ambion, Austin, TX, USA).
###end p 45
###begin title 46
Treatment of embryos with VEGF receptor tyrosine kinase inhibitors
###end title 46
###begin p 47
Embryos were treated with an inhibitor of vascular endothelial growth factor receptor tyrosine kinase (VEGFRTK inhibitors, Calbiochem, EMD Bioscience, CA, USA). The embryos were incubated in inhibitor solution at 25 mumol/L (stock solution in DMSO at 10 mmol/L) from one-cell stage onwards. They were dechorionated at 24 hpf with continuous exposure to inhibitors until 48 hpf. Control experiments were set up from the same clutches of embryos and were exposed to equal volume of DMSO for comparison.
###end p 47
###begin title 48
Vascular endothelial growth factor (VEGF) injection
###end title 48
###begin p 49
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human VEGF protein (BD Bioscience, Bedford, MA, USA) was prepared in 1 mg/mL in water. Embryos at 1-4 cell stage were injected with VEGF (2 ng) into the yolk sac and its effect on angiogenesis was examined at 96 hpf.
###end p 49
###begin title 50
Real-time quantitative RT-PCR (Q-PCR)
###end title 50
###begin p 51
###xml 80 89 80 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 263 265 263 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 295 306 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 380 381 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
cDNA from 48 and 96 hpf embryos were reverse transcribed from RNA and Q-PCR for survivin was performed using the SYBR green PCR master mix (Applied Biosystems, Foster City, CA, USA). Expression level was presented as fold-change calculated using the comparative CT method as described [27] with beta-actin as the internal reference. Primer sequences for Q-PCR were shown in Table 1.
###end p 51
###begin title 52
Statistical analysis
###end title 52
###begin p 53
Results were expressed as mean +/- SEM unless otherwise stated. Comparisons between groups of data were evaluated by Mann-Whitney U and Kruskal-Wallis Test where appropriate. P-value of less than 0.05 was considered statistically significant.
###end p 53
###begin title 54
Authors' contributions
###end title 54
###begin p 55
ACHM carried out the microinjection and molecular studies and wrote the manuscript. RL carried out the microinjection in some experiments. PKC carried out the confocal microscopy. JL and LC performed the histological sectioning of embryos. AM, CV and RL participated in the design of the study. AYHL conceived of the study, and participated in its design and coordination and wrote the manuscript. All authors read and approved the final manuscript.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Additional File 1
###end title 57
###begin p 58
Blood circulation in wild-type embryos. In wild-type embryos, normal axial circulation is observed as well as circulation in ISV and DLAV.
###end p 58
###begin p 59
Click here for file
###end p 59
###begin title 60
Additional File 2
###end title 60
###begin p 61
Blood circulation in survivin morphants. In survivin morphants, normal axial circulation is observed but circulation in ISV and DLAV was absent.
###end p 61
###begin p 62
Click here for file
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
We would like to thank Dr. Stephen C Ekker, Department of Genetics, Cell Biology and Development, University of Minnesota, MN, USA for his helpful discussion and comments on the manuscript. We also thanked Dr. S.H. Cheng and the Confocal Facility in City University of Hong Kong for focal microscopy. Thanks are extended to Jessie Fu, Babs Kwok and Tommy Kwan for performing some of the microinjection experiments and to Mr. Howard Chow for part of the molecular studies.
###end p 64
###begin p 65
This work was supported by RGC grant (HKU 7488/04M and 7520/06M) and small project funding from CRCG (HKU).
###end p 65
###begin article-title 66
Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm
###end article-title 66
###begin article-title 67
Validating survivin as a cancer therapeutic target
###end article-title 67
###begin article-title 68
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
###end article-title 68
###begin article-title 69
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation
###end article-title 69
###begin article-title 70
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
###end article-title 70
###begin article-title 71
###xml 68 77 <span type="species:ncbi:7955">zebrafish</span>
Genes with homology to mammalian apoptosis regulators identified in zebrafish
###end article-title 71
###begin article-title 72
###xml 55 64 <span type="species:ncbi:7955">zebrafish</span>
Characterization of expanded intermediate cell mass in zebrafish chordin morphant embryos
###end article-title 72
###begin article-title 73
###xml 26 35 <span type="species:ncbi:7955">zebrafish</span>
Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant
###end article-title 73
###begin article-title 74
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting
###end article-title 74
###begin article-title 75
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish angiogenesis: A new model for drug screening
###end article-title 75
###begin article-title 76
###xml 48 57 <span type="species:ncbi:7955">zebrafish</span>
Identification of 315 genes essential for early zebrafish development
###end article-title 76
###begin article-title 77
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
###end article-title 77
###begin article-title 78
VEGF-mediated survivin expression in neuroblastoma cells
###end article-title 78
###begin article-title 79
###xml 14 23 <span type="species:ncbi:7955">zebrafish</span>
Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis
###end article-title 79
###begin article-title 80
Phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development
###end article-title 80
###begin article-title 81
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
###end article-title 81
###begin article-title 82
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish G protein {gamma}2 is required for VEGF signaling during angiogenesis
###end article-title 82
###begin article-title 83
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis
###end article-title 83
###begin article-title 84
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
The antiapoptotic protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells
###end article-title 84
###begin article-title 85
###xml 47 54 <span type="species:ncbi:8355">Xenopus</span>
Survivin increased vascular development during Xenopus ontogenesis
###end article-title 85
###begin article-title 86
###xml 34 43 <span type="species:ncbi:7955">zebrafish</span>
Patterning of angiogenesis in the zebrafish embryos
###end article-title 86
###begin article-title 87
Preservation of duplicate genes by complementary, degenerative mutations
###end article-title 87
###begin article-title 88
Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer
###end article-title 88
###begin article-title 89
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant
###end article-title 89
###begin article-title 90
###xml 41 50 <span type="species:ncbi:7955">zebrafish</span>
Regulation of primitive hematopoiesis in zebrafish embryos by the death receptor gene
###end article-title 90
###begin article-title 91
###xml 56 65 <span type="species:ncbi:7955">zebrafish</span>
Syndecan-2 is essential for angiogenic sprouting during zebrafish development
###end article-title 91
###begin article-title 92
###xml 70 79 <span type="species:ncbi:7955">zebrafish</span>
The role of phospholipase C gamma 1 in primitive hematopoiesis during zebrafish development
###end article-title 92

